Methylation of LDHA Gene Promoter Region and Regulation of LDHA Expression in Cancer Cells

LDHA基因启动子区甲基化及癌细胞中LDHA表达的调控

基本信息

  • 批准号:
    13470518
  • 负责人:
  • 金额:
    $ 1.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

In cancer patients high lactate dehydrogenase (LDH) activity has been often observed in their sera, and unusual extra band of LDH isoenzyme has been sometimes observed in cancer patients. The extra band is often adjacent to LDH2 and between LDH2 and LDH3 isoenzyme bands (designated as LDH2ex), however, molecular nature of the LDH2ex has not been clarified yet. We experienced a 4-year-old boy with metastasized hereditary retinoblastoma, whose serum showed the LDH2ex in addition to the 5 normal isoenzymes. A retinoblastoma cell line, NCC-RbC-51 established from the surgical specimen obtained from this patient showed also an unusual isoenzyme pattern composed of only 2 bands : the normal LDH1 band and the LDH2ex. We analyzed molecular mechanism underlying this aberrant LDH isoenzyme pattern of the NCC-RbC-51. Northern blot analysis using human LDHA cDNA as the probe revealed that the NCC-RbC-51 line did not express normal/somatic LDHA mRNA but a small amount of LDHA relative mRNA with sli … More ghtly higher molecular weight than that of the normal LDHA mRNA. Treatment with 50 μM of 5-azadeoxycytidine induced the expression of the normal LDH2, 3, 4 and 5 isoenzymes in the NCC-RbC-51, suggesting that the transcription of the normal LDHA was silenced by the promoter methylation. The sodium bisulfite treatment and PCR analysis revealed that in the LDHA gene, the CpG island in the region encoding the 5' non-coding sequence (exon a, Takano and Li, 1990) was completely methylated .The RT-PCR and direct sequencing revealed that the NCC-RbC-51 expressed an RNA having the sequence of the human counterpart of the murine testis-specific variant that has exon 0 (-434 to -232) instead of exon a (-2248 to -2172) for the 5' non-coding sequence. Taken together, from these results the mechanism underlying the abnormal LDH isoenzyme pattern in the NCC-RbC-51 line was presumed as follows : I) somatic LDHA was silenced by the promoter hypermethylation around exon a, leaving only LDH1 (B4) as for the normal isoenzyme ; and ii) the LDH2ex (B3A'1) was constituted with one molecule of the testis-specific splicing variant of the LDHA (A') and three molecules of the normal LDHB. Although it remains to determine whether the novel expression of the LDH2ex in the tumor occurred as a result of the suppression of somatic LDHA transcription or independent event, we think this mechanism explains at least, a part of LDH2ex-involved abnormal isoenzyme patterns reported previously. Less
在癌症患者的血清中经常观察到高乳酸脱氢酶(LDH)活性,并且在癌症患者中有时观察到异常的LDH同工酶带。这条额外的条带通常位于LDH2附近以及LDH2和LDH3同工酶带之间(称为LDH2ex),但LDH2ex的分子性质尚未明确。我们经历了一个4岁的男孩转移遗传性视网膜母细胞瘤,他的血清显示LDH2ex除了5正常同工酶。从该患者手术标本中建立的视网膜母细胞瘤细胞系nc - rbc -51也显示出异常的同工酶模式,仅由2个条带组成:正常的LDH1条带和LDH2ex条带。我们分析了NCC-RbC-51这种异常LDH同工酶模式的分子机制。以人LDHA cDNA为探针的Northern blot分析显示,NCC-RbC-51细胞系不表达正常/体细胞LDHA mRNA,只表达少量LDHA相对mRNA,分子量略高于正常LDHA mRNA。50 μM的5-azadeoxycytidine诱导NCC-RbC-51中正常LDH2、3、4和5同工酶的表达,表明正常LDHA的转录被启动子甲基化沉默。亚硫酸氢钠处理和PCR分析显示,在LDHA基因中,编码5'非编码序列(外显子a, Takano and Li, 1990)区域的CpG岛完全甲基化。RT-PCR和直接测序结果显示,nc - rbc -51表达的RNA序列与小鼠睾丸特异性变异的人类对应序列相同,其5'非编码序列具有外显子0(-434至-232)而不是外显子a(-2248至-2172)。综上所述,根据这些结果,NCC-RbC-51细胞系中LDH同工酶异常模式的机制可以推测如下:1)体细胞LDHA被外显子a周围的启动子超甲基化沉默,只留下LDH1 (B4)作为正常同工酶;ii) LDH2ex (B3A'1)由LDHA的睾丸特异性剪接变体(A')和正常LDHB的三个分子组成。尽管LDH2ex在肿瘤中的新表达是由于抑制体细胞LDHA转录还是独立事件的结果仍有待确定,但我们认为这一机制至少解释了先前报道的LDH2ex参与异常同工酶模式的一部分。少

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Maekawa M: "Cancer Biomarker"Jpn J Clin Pathol. Suppl.124. 15-20 (2003)
前川 M:“癌症生物标志物”Jpn J Clin Pathol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
前川真人: "Electrophoretic variant of lactate dehydrogenase isoenzyme and selective promoter methylation of the LDHA gene in a human retinoblastoma cell line"Clinical Chemistry. 48・11. 1938-1945 (2002)
Masato Maekawa:“人视网膜母细胞瘤细胞系中乳酸脱氢酶同工酶的电泳变体和选择性启动子甲基化”临床化学48·11(2002)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Maekawa M, Inomata M, Sasaki MS, Kaneko A, Ushiama M, Sugano K, Takayama J, Kanno T: "Electrophoretic variant of a lactate dehydrogenase isoenzyme and selective promoter methylation of the LDHA gene in a human retinoblastoma cell line"Clin Chem. 48. 1938-
Maekawa M、Inomata M、Sasaki MS、Kaneko A、Ushiama M、Sugano K、Takayama J、Kanno T:“人视网膜母细胞瘤细胞系中乳酸脱氢酶同工酶的电泳变体和 LDHA 基因的选择性启动子甲基化”Clin Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Maekawa M: "Lactate Dehydrogenase (LD)"Jpn J Clin Pathol. Suppl.116. 81-89 (2001)
Maekawa M:“乳酸脱氢酶(LD)”Jpn J Clin Pathol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAEKAWA Masato其他文献

MAEKAWA Masato的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAEKAWA Masato', 18)}}的其他基金

To improve quality of cancer gene panel tests by strategic implementation of external quality assessment scheme
通过战略性实施外部质量评估计划来提高癌症基因组测试的质量
  • 批准号:
    20K07823
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploratory Research for Fetal Programming Effects by Using Omics Analysis including Epigenomics
使用组学分析(包括表观基因组学)对胎儿编程效应进行探索性研究
  • 批准号:
    24390144
  • 财政年份:
    2012
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Property investigation of circulating tumor cells, primary and metastatic cancer tissues by use of whole genome sequencing and application to laboratory testing
利用全基因组测序对循环肿瘤细胞、原发性和转移性癌症组织进行特性研究并应用于实验室测试
  • 批准号:
    23659295
  • 财政年份:
    2011
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Mechanism of abnormalities in clinical laboratory data by analysis of epigenome, genome and miRome
通过表观基因组、基因组和miRome分析临床实验室数据异常的机制
  • 批准号:
    21390180
  • 财政年份:
    2009
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Clinical Assessment of Malondialdehyde-Modified LDL for Atherosclerotic Disorders
丙二醛修饰 LDL 治疗动脉粥样硬化性疾病的临床评估
  • 批准号:
    13557225
  • 财政年份:
    2001
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

基于hTERT promoter突变的脑胶质瘤分子异质性可视化及靶向的研究
  • 批准号:
    82373403
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目

相似海外基金

The role of Alpha1-Adrenergic Receptors Promoter Methylation in Cerebral Autoregulation in Fetus
α1-肾上腺素能受体启动子甲基化在胎儿大脑自动调节中的作用
  • 批准号:
    10657080
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Clinical significance and application of promoter DNA methylation of HOPX in thyroid cancer
HOPX启动子DNA甲基化在甲状腺癌中的临床意义及应用
  • 批准号:
    21K07225
  • 财政年份:
    2021
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker Assay
预分析因素对球母细胞瘤 MGMT 启动子甲基化生物标志物测定的影响
  • 批准号:
    9975358
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
Development of DNA methylation-resistant promoter for long-term stable expression in horticultural plants
开发用于园艺植物中长期稳定表达的DNA甲基化抗性启动子
  • 批准号:
    20K21318
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker Assay
预分析因素对球母细胞瘤 MGMT 启动子甲基化生物标志物测定的影响
  • 批准号:
    10415839
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
Development of a biomarker for clarifying the antemortem experiences using DNA methylation of the NR3C1 promoter region in brains from pediatric victims of physical abuse
利用遭受身体虐待的儿科受害者大脑中 NR3C1 启动子区域的 DNA 甲基化开发生物标志物,用于澄清生前经历
  • 批准号:
    16K15399
  • 财政年份:
    2016
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Stereotactic image-based histological analysis reveals a correlation between 11C-methionine uptake and MGMT promoter methylation in non-enhancing gliomas
基于立体定向图像的组织学分析揭示非增强神经胶质瘤中 11C-甲硫氨酸摄取与 MGMT 启动子甲基化之间的相关性
  • 批准号:
    16K20033
  • 财政年份:
    2016
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Association study of the polymorphic region and methylation in the serotonin transporter gene promoter in the clinical response to drug treatment in obsessive-compulsive disorder
5-羟色胺转运蛋白基因启动子多态性区域与甲基化在强迫症药物治疗临床反应中的关联研究
  • 批准号:
    15K19734
  • 财政年份:
    2015
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Changes in histone modifications and DNA methylation of the Cyp11a1(P450scc) promoter region in rat granulosa cells undergoing
大鼠颗粒细胞Cyp11a1(P450scc)启动子区组蛋白修饰和DNA甲基化的变化
  • 批准号:
    15K20146
  • 财政年份:
    2015
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Elucidating the function of promoter DNA methylation status on IL1B gene regulation in human articular chondrocytes
阐明启动子 DNA 甲基化状态对人关节软骨细胞 IL1B 基因调控的功能
  • 批准号:
    26870031
  • 财政年份:
    2014
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了